Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01806571 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Untreated Adult Acute Myeloid Leukemia

Interventions

DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
OTHER: Laboratory Biomarker Analysis
DRUG: Nilotinib
OTHER: Pharmacological Study

Sponsor

Mayo Clinic

Collaborators

[object Object]